Mount Sinai Team Uses Novel Treatment Approach for Antibody-Mediated Insulin Resistance in a Patient With Cirrhosis
In an unusual and complex case, a multidisciplinary team developed a treatment for a patient with end-stage liver disease and insulin antibody-mediated insulin resistance.